Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Helena Edlin"'
Autor:
Samantha Hyndman, Helena Edlin, Emma Laing, Edward CF Wilson, Subash Somalanka, James Hunter, James Richards, Mohammed Hossain, Dominic Summers, Matthew Slater, Matthew Bartlett, Vasilis Kosmoliaptsis, Regin Lagaac, Anna Sidders, Claire Foley, Valerie Hopkins, Chloe Fitzpatrick-Creamer, Cara Hudson, Sam Turner, Andrew Tambyraja, Sam Dutta, Sarah Lawman, Tracey Salter, Mohammed Aslam, Atul Bagul, Rajesh Sivaprakasam, George Smith, Zia Moinuddin, Simon Knight, Paul Gibbs, Reza Motallebzadeh, Nicholas Barnett, Gavin Pettigrew, Alison Deary, Veena Surendrakumar, Tobi Ayorinde, Igor Chipurovski, Subhankar Paul, Klaus Bond, Elizabeth Hardy, Joanne Widdup, Rachael Potter, Elisabeth Pugh, Karen Parsons, Kathryn Lafferty, Kate Crawford, Amy Bolsworth, Naavalah Ngwa-Ndifor, Rani Badhan, Anna Jerram, Jessica Lai, Joyce Banda, Janet Bendle, Maria Morgan, William Owen, Sue Dawson, Simon Daniel, Karen Allsop, Sarah-Jane Carmichael, Tom Eadie, Rona Lochiel, Midel Lena, Soundrie Padayachee, Philip Eldridge, May Rabuya, Jashree Patel, Abbas Ghazanfar, Judy Van Selm, Caroline Bodneck, Martia Augustin, Kwame Ansu, Nalin Khosla, Kashif Burney, Karen Dear, Carl Tiivas, Maria Truslove, Andrew Beech, Sarah Brand, Darren Cheal, Mel Smith, Kate Trivedi, Adnan Bajwa, John Kerr, Ana Fleet, Lianne Chapman, Sarah Gee, Thanuja Weerasinghe, Paris Cai, Judith Long, Tracey Rowe, Jeremy Crane, Mary Quashie-Akponeware
Publikováno v:
BMJ Open, Vol 9, Iss 7 (2019)
Introduction Arteriovenous fistulas (AVFs) are considered the best and safest modality for providing haemodialysis in patients with end-stage renal disease. Only 20% of UK centres achieve the recommended 80% target for achieving dialysis of the preva
Externí odkaz:
https://doaj.org/article/fc18340fab72401ea227a536dcd21c1f
Autor:
Chadi Rakieh, Pauline Ho, Ian N. Bruce, M. Yvonne Alexander, Yasmeen Ahmad, Sarah Skeoch, Sahena Haque, Rachel Gorodkin, Helena Edlin
Publikováno v:
Haque, S, Skeoch, S, Rakieh, C, Edlin, H, Ahmed, Y, Ho, P, Gorodkin, R, Yvonne Alexander, M & Bruce, I 2018, ' Progression of subclinical and clinical cardiovascular disease in a UK SLE cohort: the role of classic and SLE-related factors. ', Lupus Science & Medicine, vol. 5, no. 1 . https://doi.org/10.1136/lupus-2018-000267
Lupus Science & Medicine
Lupus Science & Medicine
ObjectivesWe aimed to describe the rate and determinants of carotid plaque progression and the onset of clinical cardiovascular disease (CVD) in a UK SLE cohort.MethodsFemale patients with SLE of white British ancestry were recruited from clinics in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::040e20ccf59f1cc053fce2692eea96a7
https://e-space.mmu.ac.uk/621515/
https://e-space.mmu.ac.uk/621515/
Autor:
Dpm Symmons, Helena Edlin, James M. Gwinnutt, Ian N. Bruce, Hoda Mirjafari, Alex J. MacGregor, J. Chipping, M O'Sullivan, S. M. M. Verstappen, Sarah Skeoch
Publikováno v:
Poster Presentations.
Background Carotid artery intimal medial thickness (IMT) on ultrasound (US) is a validated measure of subclinical cardiovascular (CV) disease. Rates of IMT progression of 0.001cm/year1 have been observed in the general population and faster progressi
Autor:
Jacqueline R. Chipping, Paul Welsh, Suzanne M M Verstappen, Naveed Sattar, Mark Lunt, Ian N. Bruce, P. A. Wilson, Helena Edlin, Tarnya Marshall, Diane Bunn, Hoda Mirjafari, Deborah P M Symmons
Publikováno v:
Annals of the Rheumatic Diseases
Background We measured N-terminal pro-brain natriuretic peptide (NT-pro-BNP), a marker of cardiac dysfunction, in an inception cohort with early inflammatory polyarthritis (IP) and assessed its association with disease phenotype, cardiovascular disea
Autor:
Richard W J Lee, Clive Handler, Helena Edlin, Ian N. Bruce, Christopher P. Denton, Chadi Rakieh, Geoge Kitas, Rhodri Martin, Sheryl Mitchell, Athol U. Wells, Tracey E. Toms, Geraldine Brough, Joanna Shelmerdine, Yasmeen Ahmad, Carol M. Black, Sahena Haque, David D'Cruz, Wan-Fai Ng, Madelynn Chan, Patricia Owen, Mark N. Lazarus, Benjamin E. Schreiber, Tabitha Turner-Stokes, David A. Isenberg, Louise Parker, Christopher J Valerio, Tanaka Ngcozana, J. Dunphy, Gerry Coghlan, Voon H Ong, Neil McHugh, Michael R. Ehrenstein, Maria Juarez, Elizabeth Price, Gregory J. Keir, Simon J. Bowman
Publikováno v:
Rheumatology. 50:iii40-iii42
Publikováno v:
European journal of internal medicine. 25(8)
Autor:
L. Mercer, Kath D. Watson, Nicola J Goodson, M Lunt, Dpm Symmons, K D Watson, Gabriel S. Panayi, KL Hyrich, M. H. Ma, David Scott, W G Dixon, Fowzia Ibrahim, Louise K. Mercer, K. Morgan, Jonathan L. Marks, Andrew Ustianowski, P. A. Wilson, Z. Fekete, Louise C. Pollard, T. Gibson, Gabrielle H. Kingsley, Tarnya Marshall, D P Symmons, Kimme L. Hyrich, IN Bruce, William G Dixon, Nicola J. Gullick, Helena Edlin, Hoda Mirjafari, Alan Mistlin, Timothy L. Jones, Valentine Charlton-Menys, Jonathan D. Rees, James N. Galloway, S. P. Oakley, Diane Bunn, B. Kirkham
Publikováno v:
Rheumatology. 49:i21-i23
Autor:
J. Shelmerdine, Helena Edlin, Allen P. Yates, Yasmeen Ahmad, L. S. Teh, Ben Parker, Ian N. Bruce
Publikováno v:
Parker, B, Ahmad, Y, Shelmerdine, J, Edlin, H, Yates, A P, Teh, L S & Bruce, I N 2011, ' An analysis of the metabolic syndrome phenotype in systemic lupus erythematosus ', Lupus, vol. 20, no. 14, pp. 1459-1465 . https://doi.org/10.1177/0961203311416695
Systemic lupus erythematosus (SLE) is associated with an increased risk of coronary heart disease (CHD) not fully explained by classic risk factors. Metabolic syndrome (MetS) is associated with an increased risk of CHD in the general population and w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21ae2d1f484004d0054e1c09283176d3
https://doi.org/10.1177/0961203311416695
https://doi.org/10.1177/0961203311416695
Autor:
Yasmeen Ahmad, Mark Harrison, Tri Wangrangsimakul, Helena Edlin, Z I Barta, Ian N. Bruce, Joanna Shelmerdine, M. G. Pattrick, Nicola Dale, L. S. Teh
Publikováno v:
Lupus. 19(3)
We tested the hypothesis that carotid atherosclerosis in systemic lupus erythematosus (SLE) is associated with poor health-related quality of life (HRQOL), which is independent of any association with traditional risk factors (TRFs), lifestyle and so